Evolution of DNA Technology in Treating Animal Diseases

Crossmark

Main Article Content


Abstract

A single gene mutation can result in aberrant cell activity and the production of a faulty protein. The cell will certainly operate very poorly or not at all as a result of this mutation. Given that the genetic material may be a therapeutic agent; this might be seen as qualitatively distinct from other conventional drugs. Gene therapy may be able to rectify or perhaps cure the pathophysiology of a disease by changing the genetic composition of cells.  In veterinary medicine, genetic engineering has been used to xenografts, and detects, prevent, and treat illnesses.  Among the challenges that gene therapy faces include transfection, intracellular vector stability, cellular and nuclear entrance, and ethical concerns. Deficits in gene transfer vectors and a lack of knowledge about the biological interactions between these vectors and the host are two examples of fundamental challenges.

Downloads

Download data is not yet available.

Citation Metrics & Similar Scopus Articles

Data source Crossref
0
citations
Citation counts are source-specific and may differ because database coverage, reference matching, and update schedules are different. Counts are not added together. Crossref values represent citation links registered and matched by Crossref.
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Urazkeldiyeva D.A. (2027)
    Development of technology for obtaining high-purity sodium chloride with induced impurity removal and process modeling
    Kompleksnoe Ispolzovanie Mineralnogo Syra, 342(3), 56-64
  2. Feng X. (2027)
    Designing Efficient Inverted Perovskite Solar Cells with Self-Assembled Monolayer Hole Transport Layers
    Nano Micro Letters, 19(1)
  3. Zhang X. (2027)
    Rational Design of Covalent Organic Frameworks for Oxygen Electrocatalysis: Recent Advances and Mechanistic Insights
    Nano Micro Letters, 19(1)

Article Details

How to Cite
Akram, M., Umaru, I. J., Mahmood, A., Hasan, M. K., Abdulghafoor, H. A., Khan, F. S., Ozdemir, F. A., Sołowski, G., Ali, J. B., & Al-Musawi, J. M. (2025). Evolution of DNA Technology in Treating Animal Diseases. African Journal of Biochemistry and Molecular Biology Research, 2(2), 217-223. https://doi.org/10.58578/ajbmbr.v2i2.5582

References

Bresee, J. S., Glass, R. I., Ivanoff, B., & Gentsch, J. R. (1999). Current Status and Future Priorities for Rotavirus Vaccine Development, Evaluation and Implementation in Developing Countries. Vaccine, 17(18), 2207-22.
Buermans, H. P., & den Dunnen, J. T. (2014). Next Generation Sequencing Technology: Advances and Applications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1842(10), 1932-41.
Crossa, J., Pérez-Rodríguez, P., Cuevas, J., Montesinos-López, O., Jarquín, D., De Los Campos, G., Burgueño, J., González-Camacho, J. M., Pérez-Elizalde, S., Beyene, Y., & Dreisigacker, S. (2017). Genomic Selection in Plant Breeding: Methods, Models, and Perspectives. Trends in Plant Science, 22(11), 961-75.
Dong, J., Olano, J. P., McBride, J. W., & Walker, D. H. (2008). Emerging Pathogens: Challenges and Successes of Molecular Diagnostics. The Journal of Molecular Diagnostics, 10(3), 185-97.
Kleckner, N., Roth, J., & Botstein, D. (1977). Genetic Engineering In Vivo Using Translocatable Drug-Resistance Elements: New Methods in Bacterial Genetics. Journal of Molecular Biology, 116(1), 125-59.
Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K. (2022). Gene Therapy: Comprehensive Overview and Therapeutic Applications. Life Sciences, 294, 120375.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>